ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Genomic Life Achieves 2-Year HITRUST Certification

--News Direct--

(Sept. 8, 2022) – Securing an individual's healthcare data is always a priority. But instilling trust in today’s environment means exceeding expectations with security measures. Genomic Life, a genome management company with a mission of providing genetic testing and personalizing cancer support services, earned HITRUST’s certified status for its information, security, and privacy on its digital Genomic Life platform.

According to the 2021 Healthcare Data Breach Trend Report, hacking and information technology incidents targeting outpatient and specialty clinics have grown 41% in the past year. With the healthcare industry becoming more digitally integrated each year, it’s become increasingly critical to protect online healthcare data better.

Genomic Life’s achievement of a high-level certification is a new milestone in protecting sensitive member data. Genomic Life completed its annual SOC 2 Type 2 engagements as of July 1, 2020. It recently accomplished a HITRUST and NIST CSF validated assessment as of May 6th, 2022 with a certified report date of August 6th, 2022.

“Achieving the HITRUST certification puts us in company with an elite group of organizations worldwide who have also earned this designation,” said Coley Chavez, Vice President, Compliance and Operations, Genomic Life.

HITRUST Risk-based, 2-year (r2) Certified status demonstrates that Genomic Life has met federal and state regulations and is appropriately managing risk. The HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

“In today’s ever-changing threat landscape, HITRUST is continually innovating to find new and creative approaches to address challenges,” said Jeremy Huval, Chief Innovation Officer, HITRUST. “Genomic Life’s HITRUST Risk-based, 2-year Certification is evidence that they are at the forefront of industry best practices for information risk management and compliance.”

The genome management program facilitates lifetime access to genomic insights. Members receive genetic tests to prevent disease through proactive genetic screening. The program also helps diagnose diseases more accurately and tailors services and treatments.

“Security of our member information is paramount. With our platform, members will have the strongest degree of security measures in place safeguarding their information, providing one less worry for them,” said Karen Ferrell, CEO, Genomic Life. “I’m very proud of our team at Genomic Life who worked hard to attain the certifications that demonstrate the highest standards and that only a few select companies achieve.”

###

About Genomic Life:

Genomic Life accelerates the transition to genomics to deliver a proactive health ecosystem rooted in affordability, accessibility, and actionability. Understanding an individual's unique genome helps uncover health risks, informs treatment, and personalizes approaches to optimize health. Learn more here.

Contact Details

The Hoyt Organization

Kelly Reynolds

+1 310-343-3197

kreynolds@hoytorg.com

Company Website

https://genomiclife.com/

View source version on newsdirect.com: https://newsdirect.com/news/genomic-life-achieves-2-year-hitrust-certification-352408111

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.